As it ex­pands its foot­print, Mod­er­na reach­es deal to com­mer­cial­ize Covid-19 vac­cine dos­es in Mid­dle East

While the UAE leads the world with the high­est per­cent­age of res­i­dents vac­ci­nat­ed, neigh­bor­ing Sau­di Ara­bia — home to near­ly 35 mil­lion peo­ple — has lagged be­hind sig­nif­i­cant­ly. On Fri­day, Mod­er­na an­nounced that it has part­nered with the Sau­di phar­ma­ceu­ti­cal com­pa­ny Tabuk to com­mer­cial­ize its jab and fu­ture vari­ant-spe­cif­ic boost­ers in the coun­try.

Tabuk will hold mar­ket­ing au­tho­riza­tion for the vac­cine in Sau­di Ara­bia, and the agree­ment gives them the pos­si­bil­i­ty of dis­trib­ut­ing fu­ture Mod­er­na mR­NA prod­ucts.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER